RANBP1 and 22q11.2 deletion syndrome: As thalidomide and VPA both cause decreased expression of RANBP1 mRNA, mimicking haploinsufficiency of the gene in 22q11.2 Deletion Syndrome, it is plausible that it could be involved in the common teratogenic profile across syndromes.